enzalutamide

The drug is prescribed for adult men for the treatment of metastatic hormone-sensitive prostate cancer, as well as for the treatment of non-metastatic and metastatic castration-resistant prostate cancer (including cases where the disease progresses during androgen deprivation therapy or after docetaxel chemotherapy).

Form: tablets, film-coated

ATC: L02BB04

Manufacturer: Faros MT Limited

The drug is prescribed for adult men for the treatment of metastatic hormone-sensitive prostate cancer, as well as for the treatment of non-metastatic and metastatic castration-resistant prostate cancer (with or without symptoms).

Form: tablets, film-coated

ATC: L02BB04

Manufacturer: Faros MT Limited

The drug is indicated for the treatment of adult men with metastatic hormone-sensitive prostate cancer (in combination with androgen deprivation therapy), as well as for the treatment of various forms of castration-resistant prostate cancer (both non-metastatic high-risk and metastatic).

Form: capsules

ATC: L02BB04

Manufacturer: Catalent Pharma Solutions, LLC (manufacturing bulk)